ESC 365 - Identification of novel biomarkers for prediction of clinical outcome in acute myocardial infarction patients by Olink platform.

HFA Premium Access

Identification of novel biomarkers for prediction of clinical outcome in acute myocardial infarction patients by Olink platform.

Session: Poster Session 2 - Biomarkers

Topic: Prognosis (using biomarkers)

Speaker: Doctor S. Schordan (HUNINGUE, FR)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Sandra Schordan

FIRALIS SAS, HUNINGUE (France)

0 follower

24 more presentations in this session

The value of NT-proBNP in the diagnosis of cardiac disease in patients with alcoholic liver cirrhosis

Speaker: Associate Professor P. Lazarev (Moscow, RU)

Not changes in heart failure therapy but patient characteristics at admission predict unsuccessful guidance of therapy to a target of more than 30% NT-proBNP reduction

Speaker: Miss S. Stienen (Amsterdam, NL)

Sacubitril/valsartan prevents the acute increase of n-terminal brain natriuretic peptide induced by exercise training in subjects with heart failure

The diagnostic and economic implications of using a plasma nt-probnp of 300 or 400ng/litre as the threshold for ruling out the diagnosis of heart failure in a non selected british population

Speaker: Doctor J. Webb (London, GB)

Natriuretic peptides for detection of heart failure in patients with atrial fibrillation from the community

Speaker: Professor F. Rutten (Utrecht, NL)

Access the full session

Poster Session 2 - Biomarkers

Speakers: Doctor S. Schordan, Associate Professor P. Lazarev, Miss S. Stienen, Doctor J. Webb, Professor F. Rutten

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources